These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3023703)

  • 1. Modification of acute murine cytomegalovirus adrenal gland infection by adoptive spleen cell transfer.
    Shanley JD
    J Virol; 1987 Jan; 61(1):23-8. PubMed ID: 3023703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine cytomegalovirus adrenalitis in athymic nude mice.
    Shanley JD; Pesanti EL
    Arch Virol; 1986; 88(1-2):27-35. PubMed ID: 3006642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors.
    Reddehase MJ; Jonjić S; Weiland F; Mutter W; Koszinowski UH
    J Virol; 1988 Mar; 62(3):1061-5. PubMed ID: 2828654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.
    Selgrade MK; Ahmed A; Sell KW; Gershwin ME; Steinberg AD
    J Immunol; 1976 May; 116(5):1459-65. PubMed ID: 178797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of L3T4+ lymphocyte depletion on acute murine cytomegalovirus infection.
    Erlich KS; Mills J; Shanley JD
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1765-71. PubMed ID: 2544664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of T lymphocytes in recovery from murine cytomegalovirus infection.
    Starr SE; Allison AC
    Infect Immun; 1977 Aug; 17(2):458-62. PubMed ID: 197022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice.
    Shanley JD; Thrall RS; Forman SJ
    J Infect Dis; 1997 Feb; 175(2):309-15. PubMed ID: 9203651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.
    Reddehase MJ; Weiland F; Münch K; Jonjic S; Lüske A; Koszinowski UH
    J Virol; 1985 Aug; 55(2):264-73. PubMed ID: 2991554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.
    Bukowski JF; Warner JF; Dennert G; Welsh RM
    J Exp Med; 1985 Jan; 161(1):40-52. PubMed ID: 2981954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal gland lesions with murine cytomegalovirus.
    Shanley JD; Pesanti EL
    Ann Intern Med; 1984 May; 100(5):765-6. PubMed ID: 6324627
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.
    Ho M
    Infect Immun; 1980 Mar; 27(3):767-76. PubMed ID: 6247279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. During recovery from cytomegalovirus infection T-lymphocyte subsets become selectively responsive to activation and have depressed interleukin 2 (IL2) secretion and IL2 receptor expression.
    Nicholas JA; Levely ME; Brideau RJ; Berger AE
    Microb Pathog; 1987 Jan; 2(1):37-47. PubMed ID: 2853271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE; Shellam GR
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function.
    Via CS; Shanley JD; Shearer GM
    J Immunol; 1990 Nov; 145(10):3283-9. PubMed ID: 2172381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.
    Bukowski JF; Woda BA; Welsh RM
    J Virol; 1984 Oct; 52(1):119-28. PubMed ID: 6207307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus.
    Grundy JE; Melief CJ
    J Gen Virol; 1982 Jul; 61 (Pt l)():133-6. PubMed ID: 6288849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes.
    Cheeran MC; Gekker G; Hu S; Min X; Cox D; Lokensgard JR
    J Neurovirol; 2004 Jun; 10(3):152-62. PubMed ID: 15204920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.